XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury stock
Total
Balance at Dec. 31, 2020 $ 3,193 $ 4,537,982 $ 6,432,074 $ 3,034 $ (5,815,423) $ 5,160,860
Balance (in shares) at Dec. 31, 2020 638,662       (110,565)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   17,949       17,949
Exercise of stock options $ 3 6,758       6,761
Exercise of stock options (in shares) 492          
Unrealized gain (loss), net on available-for-sale securities       24   24
Repurchase of common stock         $ (13,419) (13,419)
Repurchase of common stock (in shares)         (150)  
Foreign currency translation       (27,932)   (27,932)
Net income     315,194     315,194
Balance at Mar. 31, 2021 $ 3,196 4,562,689 6,747,268 (24,874) $ (5,828,842) 5,459,437
Balance (in shares) at Mar. 31, 2021 639,154       (110,715)  
Balance at Dec. 31, 2020 $ 3,193 4,537,982 6,432,074 3,034 $ (5,815,423) 5,160,860
Balance (in shares) at Dec. 31, 2020 638,662       (110,565)  
Increase (Decrease) in Stockholders' Equity            
Unrealized gain (loss), net on available-for-sale securities           (117)
Net income           1,056,161
Balance at Sep. 30, 2021 $ 3,199 4,626,299 7,488,235 (43,495) $ (5,829,241) 6,244,997
Balance (in shares) at Sep. 30, 2021 639,851       (110,719)  
Balance at Mar. 31, 2021 $ 3,196 4,562,689 6,747,268 (24,874) $ (5,828,842) 5,459,437
Balance (in shares) at Mar. 31, 2021 639,154       (110,715)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   16,921       16,921
Exercise of stock options $ 2 17,723       17,725
Exercise of stock options (in shares) 422          
Unrealized gain (loss), net on available-for-sale securities       (183)   (183)
Repurchase of common stock         $ (399) (399)
Repurchase of common stock (in shares)         (4)  
Foreign currency translation       8,235   8,235
Net income     403,762     403,762
Balance at Jun. 30, 2021 $ 3,198 4,597,333 7,151,030 (16,822) $ (5,829,241) 5,905,498
Balance (in shares) at Jun. 30, 2021 639,576       (110,719)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   16,293       16,293
Exercise of stock options $ 1 12,673       12,674
Exercise of stock options (in shares) 275          
Unrealized gain (loss), net on available-for-sale securities       43   43
Foreign currency translation       (26,716)   (26,716)
Net income     337,205     337,205
Balance at Sep. 30, 2021 $ 3,199 4,626,299 7,488,235 (43,495) $ (5,829,241) 6,244,997
Balance (in shares) at Sep. 30, 2021 639,851       (110,719)  
Balance at Dec. 31, 2021 $ 3,200 4,652,620 7,809,549 (69,165) $ (5,829,253) 6,566,951
Balance (in shares) at Dec. 31, 2021 640,043       (110,720)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   16,175       16,175
Exercise of stock options $ 3 4,507       4,510
Exercise of stock options (in shares) 485          
Unrealized gain (loss), net on available-for-sale securities       (4,059)   (4,059)
Repurchase of common stock         $ (12,187) (12,187)
Repurchase of common stock (in shares)         (166)  
Foreign currency translation       1,079   1,079
Net income     294,203     294,203
Balance at Mar. 31, 2022 $ 3,203 4,673,302 8,103,752 (72,145) $ (5,841,440) 6,866,672
Balance (in shares) at Mar. 31, 2022 640,528       (110,886)  
Balance at Dec. 31, 2021 $ 3,200 4,652,620 7,809,549 (69,165) $ (5,829,253) $ 6,566,951
Balance (in shares) at Dec. 31, 2021 640,043       (110,720)  
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options (in shares)           813
Unrealized gain (loss), net on available-for-sale securities           $ (7,840)
Net income           889,950
Balance at Sep. 30, 2022 $ 3,206 4,736,141 8,699,499 (224,455) $ (6,398,631) 6,815,760
Balance (in shares) at Sep. 30, 2022 641,245       (117,280)  
Balance at Mar. 31, 2022 $ 3,203 4,673,302 8,103,752 (72,145) $ (5,841,440) 6,866,672
Balance (in shares) at Mar. 31, 2022 640,528       (110,886)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   16,157       16,157
Exercise of stock options $ 2 18,110       18,112
Exercise of stock options (in shares) 416          
Unrealized gain (loss), net on available-for-sale securities       (1,106)   (1,106)
Repurchase of common stock         $ (284,311) (284,311)
Repurchase of common stock (in shares)         (3,286)  
Foreign currency translation       (79,707)   (79,707)
Net income     273,360     273,360
Balance at Jun. 30, 2022 $ 3,205 4,707,569 8,377,112 (152,958) $ (6,125,751) 6,809,177
Balance (in shares) at Jun. 30, 2022 640,944       (114,172)  
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation   16,436       16,436
Exercise of stock options $ 1 12,136       12,137
Exercise of stock options (in shares) 301          
Unrealized gain (loss), net on available-for-sale securities       (2,675)   (2,675)
Repurchase of common stock         $ (272,880) (272,880)
Repurchase of common stock (in shares)         (3,108)  
Foreign currency translation       (68,822)   (68,822)
Net income     322,387     322,387
Balance at Sep. 30, 2022 $ 3,206 $ 4,736,141 $ 8,699,499 $ (224,455) $ (6,398,631) $ 6,815,760
Balance (in shares) at Sep. 30, 2022 641,245       (117,280)